Innovation & intellectual property · 27/12/2013Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension for Recombinant Human Parathyroid Hormone Patent
Summary
The U.S. Patent and Trademark Office has issued an order granting a one-year interim extension under 35 U.S.C. 156(d)(5) for U.S. Patent No. 5,496,801, which covers a recombinant human parathyroid hormone
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →